Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti-angiogenic therapy

Mouadh Nefiss; Hichem Abid; Mohamed Amine Gharbi; Ramzi Bouzidi; Anis Teborbi

doi:10.1002/ccr3.6599

Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti-angiogenic therapy

Clin Case Rep. 2022 Nov 15;10(11):e6599. doi: 10.1002/ccr3.6599. eCollection 2022 Nov.

Authors

Mouadh Nefiss^{1

2}, Hichem Abid^{1

2}, Mohamed Amine Gharbi^{1

2}, Ramzi Bouzidi^{1

2}, Anis Teborbi^{1

2}

Affiliations

¹ Department of Orthopaedic Surgery Mongi Slim University Hospital La Marsa Tunisia.
² Tunis El Manar University Tunis Tunisia.

Abstract

Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS). Surgical decision-making remains a subject of controversy. We report a case of pelvic bone metastasis from RCC, 2 months after nephrectomy and surgery of a revealing clavicular metastasis.

Keywords: bone metastases; renal cell carcinoma; surgery; targeted therapy.

Publication types

Case Reports